Myelofibrosis | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Myelofibrosis (Companion Faculty Lecture)

Featuring a slide presentation and related discussion from Dr Ruben Mesa, including the following topics: Efficacy and safety of FDA-approved JAK inhibitors for the management of myelofibrosis (MF) (0:00) Emerging JAK inhibitors under Phase III evaluation for MF (6:59) Current guidelines and strategies for managing MF (13:53) Emerging data with novel agents and strategies for MF (17:31) Splenic response and symptomology in patients with MF (25:36) CME information and select publications

Om Podcasten

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.